DAVID Arthur

Dr. DAVID Arthur

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
OEOlivier Espitia
Olivier Espitia
FDFrédéric Douane
Frédéric Douane
JHJeanne Hersant
Jeanne Hersant
FAFabrice Abbadie
Fabrice Abbadie
JSJonathan Sobocinski
Jonathan Sobocinski
BMBlandine Maurel
Blandine Maurel

4 January 2022 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
DADAVID Arthur
DAVID Arthur
FTFrédéric Thony
Frédéric Thony
CGCostantino Del Giudice
Costantino Del Giudice
GGGilles Goyault
Gilles Goyault
RLRomaric Loffroy
Romaric Loffroy
FIFor The Société Française D’imagerie Cardiovasculaire Diagnostique Et Interventionnelle
For The Société Française D’imagerie Cardiovasculaire Diagnostique Et Interventionnelle

1 July 2019 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
DADAVID Arthur
DAVID Arthur
RLR. Liberge
R. Liberge
JMJ. Meyer
J. Meyer
OMO. Morla
O. Morla
FLF. Leaute
F. Leaute
FDF. Douane
F. Douane

1 October 2020 in Diagnostic and Interventional Imaging
Verified
Journal Article
Closed access
DADAVID Arthur
DAVID Arthur
EFE. Frampas
E. Frampas
FDF. Douane
F. Douane
CPC. Perret
C. Perret
FLF. Leaute
F. Leaute
JBJ. Branchereau
J. Branchereau

1 September 2021 in Journal of Gynecology Obstetrics and Human Reproduction
Verified
Journal Article
Closed access
AGAlizé Gilbert
Alizé Gilbert
TTThibault Thubert
Thibault Thubert
VDVincent Dochez
Vincent Dochez
ARAnne-Sophie Riteau
Anne-Sophie Riteau
MDMathilde Ducloyer
Mathilde Ducloyer
DADAVID Arthur
DAVID Arthur

19 December 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
JPJules Pouchot
Jules Pouchot
CACrombé Amandine
Crombé Amandine
LBLuc Burlet
Luc Burlet
FFFadi Farah
Fadi Farah
PBPierre Baseilhac
Pierre Baseilhac
EJEva Jambon
Eva Jambon
Background/Objectives: This multicentric study aimed to evaluate the efficacy and safety of prostatic artery embolization (PAE) to remove indwelling urinary catheter (IUC) in patients with symptomatic benign prostatic hyperplasia (BPH). Secondary objectives were to identify features associated with post-PAE catheter-free survival (PCFS). Methods: All consecutive patients who underwent PAE for IUC related to BPH with a follow-up of at least 2 years (except for early death) in 6 French University Hospitals were retrospectively included. Clinical efficacy was defined as the removal of the IUC after PAE (through a trial without catheter [TWOC]) and evaluated at regular intervals. Chi-square tests, Wilcoxon tests and multivariable binary logistic regressions were utilized to investigate predictors of TWOC success. Univariable and multivariable Cox regressions were utilized to investigate predictors of PCFS in patients with TWOC success. Results: 140 men with IUC (median age: 82.5 years, interquartile range [IQR] = 73–88.2 years, range: 46–100) who underwent PAE between January 2017 and March 2021 were included. Initial successful catheter removal (TWOC success) following PAE occurred in 113/140 (80.7%) patients, and 3/140 (2.1%) patients encountered major complications. In patients with TWOC success, PCFS at 6 months, 1 year and 2 years were 87.5% (95%CI: 81.4–94.1), 84.4% (95%CI: 77.7–91.7) and 79% (71.3–87.4), respectively. No independent predictive factors for TWOC success and PCFS were identified. Conclusions: PAE should be considered as a safe option with good clinical efficacy in the short and long term for elderly and inoperable patients with IUC due to symptomatic BPH.